.Nature Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint requires introduction of individuals with MASLD and measurement of liver outcomes in cardio-- kidney-- metabolic tests, when information propose mechanistically probable benefits and medical safety-- and details factors to consider for test concept as well as regulatory approval.